Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Qiagen    QGEN   NL0012169213

QIAGEN

(QGEN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about QIAGEN
07/16QIAGEN N.V. : to Report Second Quarter and First Half of 2019 Results
BU
07/15QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
07/09QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
06/28QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
06/25QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
06/25QIAGEN : Clinical Insight surpasses 1 million patient test cases analyzed and in..
AQ
06/24QIAGEN N.V. : Release of a capital market information
EQ
06/21QIAGEN : New NGS panel for rare and inherited diseases with advanced bioinformat..
AQ
06/21QIAGEN : QCI-Lab performing expanded carrier screening boosts efficiency by 80%
AQ
06/20QIAGEN : Clinical Insight Surpasses 1 Million Patient Test Cases Analyzed and In..
BU
06/19QIAGEN : and McKesson Agree to Distribute QIAstat-Dx Syndromic Testing Solution ..
BU
06/18QIAGEN : to deliver genomic insights for Japan's new molecular oncology clinical..
BU
06/18QIAGEN N.V. : Release of a capital market information
EQ
06/17QIAGEN : to embrace global initiative to combat antibiotic resistance and launch..
PU
06/14QIAGEN : launches novel NGS panel for rare and inherited diseases with advanced ..
PU
More most relevant news
All news about QIAGEN
07/16QIAGEN N.V. : to Report Second Quarter and First Half of 2019 Results
BU
07/15QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
07/09QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
06/28QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
06/25QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
06/25QIAGEN : Clinical Insight surpasses 1 million patient test cases analyzed and in..
AQ
06/24QIAGEN N.V. : Release of a capital market information
EQ
06/21QIAGEN : New NGS panel for rare and inherited diseases with advanced bioinformat..
AQ
06/21QIAGEN : QCI-Lab performing expanded carrier screening boosts efficiency by 80%
AQ
06/20QIAGEN : Clinical Insight Surpasses 1 Million Patient Test Cases Analyzed and In..
BU
More news
Sector news : Biotechnology & Medical Research - NEC
09:05aGilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis
DJ
07/17GILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave
DJ
07/16As steep patent cliff looms, Shionogi moves to develop its own U.S. sales sta..
RE
07/16GSK's two-drug HIV Dovato treatment meets main goal in study
RE
07/15Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
More sector news : Biotechnology & Medical Research - NEC
Upcoming event on QIAGEN